在患有机械心脏门的患者中进行外科手术桥梁治疗
Nivedha Balaji1, Oluwafemi Olukayode1, Fardeen Faiz2
1Internal Medicine, Northeast Georgia Medical Center Gainesville, Gainesville, USA.
Cureus
|April 19, 2024
概括
机械心脏门 (MHVs) 需要抗凝剂. 使用低分子量肝素素 (enoxaparin) 的桥梁疗法无法预防MHV患者的急性血栓,这突显了当前指导方针中的差距.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 血栓形成研究研究
背景情况:
- 机械心脏门 (MHV) 容易发生血栓形成,因此需要终身使用维生素K对抗剂 (VKA) 进行抗凝治疗.
- 使用未分离氨酸 (UFH) 或低分子量氨酸 (LMWH) 进行周围手术桥梁抗凝治疗是减轻血栓栓塞风险的常见做法.
- 目前的临床指南缺乏关于MHVs患者最佳抗凝管理的最终建议.
研究的目的:
- 介绍一项关于机械心脏门患者抗凝管理的案例研究.
- 突出在MHVs的背景下与桥梁治疗相关的潜在并发症.
- 为了强调对有机心脏门的患者需要精细的抗凝策略的需要.
主要方法:
- 一个77岁的女性患者的病例报告,她患有机械心脏门.
- 在外科手术期间,使用埃诺沙巴林 (LMWH) 启动了桥梁抗凝药.
- 记录了急性血栓的临床过程和发展.
主要成果:
- 尽管经手术期间与恩沙巴林进行了桥接,但患者出现了急性血栓.
- 这一案例说明了即使使用标准的桥梁协议也会发生血栓栓塞事件.
- 这些发现表明,目前对MHV患者的桥梁策略存在局限性.
结论:
- 这一案例凸显了机械心脏门的血栓生成性和抗凝管理的挑战.
- 当前的桥梁协议可能无法在所有MHV患者中预防血栓栓塞事件.
- 需要进行进一步的研究,以建立基于证据的I类抗凝药建议,用于MHV患者.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
01:26Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
01:27Mitral Stenosis IV: Nursing Management
425
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
425
01:22Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
01:29Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761